2017Zhonghua heyixue yu fenzi yingxiang zazhiRequires access

Clinical application and advance of regadenoson stress myocardial perfusion imaging

Dongzhu Yang, Lei Wang

Open publisher page 0 citations

Abstract

Vasodilator stress MPI plays an important role in the detection of abnormal myocardial perfusion. Currently as the only selective A2A adenosine receptor agonist approved by FDA, the new myocardial stress agent regadenoson has been increasingly used in vasodilator stress MPI on clinic. This review describes the pharmacologic properties and overviews the clinical data on regadenoson, especially its diagnostic efficacy, prognosis predicting value and adverse effect as a vasodilator stress agent. Key words: Myocardial perfusion imaging; Adenosine A2 receptor agonists; Trends

About this research paper

What this paper is about

Vasodilator stress MPI plays an important role in the detection of abnormal myocardial perfusion. Currently as the only selective A2A adenosine receptor agonist approved by FDA, the new myocardial stress agent regadenoson has been increasingly used in vasodilator stress MPI on clinic. This review describes the pharmacologic properties and overviews the clinical data on regadenoson, especially its diagnostic efficacy, prognosis predicting value and adverse effect as a vasodilator stress agent. Key words: Myocardial perfusion imaging; Adenosine A2 receptor agonists; Trends

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Vasodilator stress MPI plays an important role in the detection of abnormal myocardial perfusion. Currently as the only selective A2A adenosine receptor agonist approved by FDA, the new myocardial stress agent regadenoson has been increasingly used in vasodilator stress MPI on clinic. This review describes the pharmacologic properties and overviews the clinical data on regadenoson, especially its diagnostic efficacy, prognosis predicting value and adverse effect as a vasodilator stress agent. Key words: Myocardial perfusion imaging; Adenosine A2 receptor agonists; Trends

Key concepts: Regadenoson, Myocardial perfusion imaging, Medicine, Vasodilation, Perfusion, Adenosine, Cardiology, Coronary vasodilator

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical application and advance of regadenoson stress myocardial perfusion imaging — Research Paper | ScholarLens